⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Cancer Vaccines Competitive Landscape Report 2026: Comprehensive Insights About 250+ Companies and 300+ Drugs - Collaborations and Licensing by Key Players Like Moderna, Merck, and IO Biotech
globenewswire.com
MRK
PD-1 and PD-L1 Inhibitors Competitive Landscape Report 2026: Comprehensive Insights on 200+ Drugs from Over 180 Companies by Company, Product Type, Stage, Route of Administration, and Molecule Type
globenewswire.com
MRK
AZN
Atopic Dermatitis Competitive Landscape Report 2026: Comprehensive Insights About 100+ Companies and 110+ Drugs
globenewswire.com
INCY
MRK
Autogenous Vaccines Market to Reach US$ 451.5 Million by 2033; Expands Amid Rising Livestock Health Needs and Precision Disease Control - Persistence Market Research
prnewswire.com
PAHC
ELAN
MRK
ZTS
MXene Market Set to Reach USD 0.29 Billion by 2032 Key Growth Trends and Opportunities
globenewswire.com
MRK
Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine
businesswire.com
MRK
Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine
businesswire.com
MRK
保険業界のAIの先陣を切るmea Platform、SEPから5,000万米ドルのグロース・エクイティによる資金調達、業界のコンバインド・レシオ改善と利益率向上へ
businesswire.com
AXS
CNA
MRK
SCOR
ACN
DXC
NOW
VERI
保険業界のAIの先陣を切るmea Platform、SEPから5,000万米ドルのグロース・エクイティによる資金調達、業界のコンバインド・レシオ改善と利益率向上へ
businesswire.com
AXS
CNA
MRK
SCOR
ACGL
保險AI領軍企業mea Platform從SEP融資5000萬美元成長股權，協助改善產業綜合成本率和利潤率
businesswire.com
AXS
CNA
MRK
SCOR
ACN
DXC
NOW
VRSK